DE102007035238A1 - Biological effect monitoring by transgenic Hydra - Google Patents
Biological effect monitoring by transgenic Hydra Download PDFInfo
- Publication number
- DE102007035238A1 DE102007035238A1 DE102007035238A DE102007035238A DE102007035238A1 DE 102007035238 A1 DE102007035238 A1 DE 102007035238A1 DE 102007035238 A DE102007035238 A DE 102007035238A DE 102007035238 A DE102007035238 A DE 102007035238A DE 102007035238 A1 DE102007035238 A1 DE 102007035238A1
- Authority
- DE
- Germany
- Prior art keywords
- hydra
- transgenic
- reporter gene
- stress factor
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- QRXWMOHMRWLFEY-UHFFFAOYSA-N isoniazide Chemical compound NNC(=O)C1=CC=NC=C1 QRXWMOHMRWLFEY-UHFFFAOYSA-N 0.000 title claims abstract description 71
- 230000009261 transgenic effect Effects 0.000 title claims abstract description 47
- 241000243251 Hydra Species 0.000 title claims abstract 21
- 238000012544 monitoring process Methods 0.000 title description 11
- 230000004071 biological effect Effects 0.000 title description 4
- 108700008625 Reporter Genes Proteins 0.000 claims abstract description 46
- 238000000034 method Methods 0.000 claims abstract description 15
- 239000013598 vector Substances 0.000 claims abstract description 15
- 230000000813 microbial effect Effects 0.000 claims description 15
- 244000052616 bacterial pathogen Species 0.000 claims description 11
- 239000003440 toxic substance Substances 0.000 claims description 11
- 231100000614 poison Toxicity 0.000 claims description 9
- 238000001514 detection method Methods 0.000 claims description 8
- 241000894006 Bacteria Species 0.000 claims description 7
- 230000001939 inductive effect Effects 0.000 claims description 6
- 241000233866 Fungi Species 0.000 claims description 4
- 241000700605 Viruses Species 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 230000005284 excitation Effects 0.000 claims description 2
- 231100000167 toxic agent Toxicity 0.000 claims 2
- 108091028043 Nucleic acid sequence Proteins 0.000 claims 1
- 239000002773 nucleotide Substances 0.000 claims 1
- 125000003729 nucleotide group Chemical group 0.000 claims 1
- 230000010354 integration Effects 0.000 abstract 1
- 241000243254 Hydra vulgaris Species 0.000 description 59
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 29
- 108090000623 proteins and genes Proteins 0.000 description 14
- 238000012360 testing method Methods 0.000 description 11
- 230000035882 stress Effects 0.000 description 10
- 239000000126 substance Substances 0.000 description 10
- 210000004027 cell Anatomy 0.000 description 9
- 208000037062 Polyps Diseases 0.000 description 7
- 238000003556 assay Methods 0.000 description 7
- 239000003651 drinking water Substances 0.000 description 7
- 235000020188 drinking water Nutrition 0.000 description 7
- 239000003344 environmental pollutant Substances 0.000 description 7
- 231100000719 pollutant Toxicity 0.000 description 7
- 238000001890 transfection Methods 0.000 description 7
- 241000251468 Actinopterygii Species 0.000 description 6
- 210000002257 embryonic structure Anatomy 0.000 description 6
- 239000002158 endotoxin Substances 0.000 description 6
- 231100000317 environmental toxin Toxicity 0.000 description 6
- 229920006008 lipopolysaccharide Polymers 0.000 description 6
- 238000000520 microinjection Methods 0.000 description 6
- 241001465754 Metazoa Species 0.000 description 5
- 230000033228 biological regulation Effects 0.000 description 5
- 230000007613 environmental effect Effects 0.000 description 5
- 108010066358 heat-shock protein 70.1 Proteins 0.000 description 5
- 229910001385 heavy metal Inorganic materials 0.000 description 5
- 239000002699 waste material Substances 0.000 description 5
- 230000007059 acute toxicity Effects 0.000 description 4
- 231100000403 acute toxicity Toxicity 0.000 description 4
- 230000019552 anatomical structure morphogenesis Effects 0.000 description 4
- 238000004113 cell culture Methods 0.000 description 4
- 239000013604 expression vector Substances 0.000 description 4
- 239000013505 freshwater Substances 0.000 description 4
- 238000001727 in vivo Methods 0.000 description 4
- 230000004044 response Effects 0.000 description 4
- 108091008146 restriction endonucleases Proteins 0.000 description 4
- 210000000130 stem cell Anatomy 0.000 description 4
- 230000035897 transcription Effects 0.000 description 4
- 238000013518 transcription Methods 0.000 description 4
- 239000003643 water by type Substances 0.000 description 4
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 3
- 102000040650 (ribonucleotides)n+m Human genes 0.000 description 3
- 108010085238 Actins Proteins 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 238000010367 cloning Methods 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000004020 luminiscence type Methods 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 230000003938 response to stress Effects 0.000 description 3
- 241000894007 species Species 0.000 description 3
- 238000011830 transgenic mouse model Methods 0.000 description 3
- BUHVIAUBTBOHAG-FOYDDCNASA-N (2r,3r,4s,5r)-2-[6-[[2-(3,5-dimethoxyphenyl)-2-(2-methylphenyl)ethyl]amino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol Chemical compound COC1=CC(OC)=CC(C(CNC=2C=3N=CN(C=3N=CN=2)[C@H]2[C@@H]([C@H](O)[C@@H](CO)O2)O)C=2C(=CC=CC=2)C)=C1 BUHVIAUBTBOHAG-FOYDDCNASA-N 0.000 description 2
- 102000007469 Actins Human genes 0.000 description 2
- 241001244729 Apalis Species 0.000 description 2
- 108010004889 Heat-Shock Proteins Proteins 0.000 description 2
- 102000002812 Heat-Shock Proteins Human genes 0.000 description 2
- 241000243262 Hydra oligactis Species 0.000 description 2
- 241000699660 Mus musculus Species 0.000 description 2
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- YKYOUMDCQGMQQO-UHFFFAOYSA-L cadmium dichloride Chemical compound Cl[Cd]Cl YKYOUMDCQGMQQO-UHFFFAOYSA-L 0.000 description 2
- 230000007665 chronic toxicity Effects 0.000 description 2
- 231100000160 chronic toxicity Toxicity 0.000 description 2
- 238000003776 cleavage reaction Methods 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 230000000254 damaging effect Effects 0.000 description 2
- -1 eYFP Proteins 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 230000001965 increasing effect Effects 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 210000001161 mammalian embryo Anatomy 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000036387 respiratory rate Effects 0.000 description 2
- 230000007017 scission Effects 0.000 description 2
- 230000035939 shock Effects 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 231100000378 teratogenic Toxicity 0.000 description 2
- 230000003390 teratogenic effect Effects 0.000 description 2
- 230000002110 toxicologic effect Effects 0.000 description 2
- 239000002351 wastewater Substances 0.000 description 2
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 1
- 241000244203 Caenorhabditis elegans Species 0.000 description 1
- 241000579895 Chlorostilbon Species 0.000 description 1
- 241000223782 Ciliophora Species 0.000 description 1
- 108091005960 Citrine Proteins 0.000 description 1
- 241000199914 Dinophyceae Species 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 241000244206 Nematoda Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 239000000090 biomarker Substances 0.000 description 1
- 238000004061 bleaching Methods 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 230000004664 chemosensory behavior Effects 0.000 description 1
- 239000011035 citrine Substances 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 108010082025 cyan fluorescent protein Proteins 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000017119 detection of oxidative stress Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 239000010976 emerald Substances 0.000 description 1
- 229910052876 emerald Inorganic materials 0.000 description 1
- 239000004029 environmental poison Substances 0.000 description 1
- 238000012851 eutrophication Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 108010021843 fluorescent protein 583 Proteins 0.000 description 1
- 231100000024 genotoxic Toxicity 0.000 description 1
- 230000001738 genotoxic effect Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 230000003760 hair shine Effects 0.000 description 1
- 230000012447 hatching Effects 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- DNHVXYDGZKWYNU-UHFFFAOYSA-N lead;hydrate Chemical compound O.[Pb] DNHVXYDGZKWYNU-UHFFFAOYSA-N 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 230000008774 maternal effect Effects 0.000 description 1
- 230000002906 microbiologic effect Effects 0.000 description 1
- 238000010172 mouse model Methods 0.000 description 1
- 150000007523 nucleic acids Chemical group 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 239000010865 sewage Substances 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 101150077082 tin gene Proteins 0.000 description 1
- 231100000816 toxic dose Toxicity 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000759 toxicological effect Toxicity 0.000 description 1
- 231100000027 toxicology Toxicity 0.000 description 1
- 230000005026 transcription initiation Effects 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 108091005957 yellow fluorescent proteins Proteins 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/60—New or modified breeds of invertebrates
- A01K67/61—Genetically modified invertebrates, e.g. transgenic or polyploid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
- C07K14/43595—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from coelenteratae, e.g. medusae
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
- A01K2217/052—Animals comprising random inserted nucleic acids (transgenic) inducing gain of function
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2227/00—Animals characterised by species
- A01K2227/70—Invertebrates
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/03—Animal model, e.g. for test or diseases
- A01K2267/0393—Animal model comprising a reporter system for screening tests
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/60—Fusion polypeptide containing spectroscopic/fluorescent detection, e.g. green fluorescent protein [GFP]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/001—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination
- C12N2830/002—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination inducible enhancer/promoter combination, e.g. hypoxia, iron, transcription factor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2520/00—Use of whole organisms as detectors of pollution
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Environmental Sciences (AREA)
- Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Plant Pathology (AREA)
- Analytical Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Animal Behavior & Ethology (AREA)
- Animal Husbandry (AREA)
- Biodiversity & Conservation Biology (AREA)
- Immunology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Die Erfindung beschreibt transgene Hydra, die beim Vorliegen wenigstens eines Stressfaktors in dem sie umgebenden Medium wenigstens ein durch den Stressfaktor induzierbares Reportergen exprimiert, die Verwendung dieser transgenen Hydra als Biomonitoringsystem sowie ein Verfahren zum Nachweis von Stressfaktoren in Proben mittels transgener Hydra. Des Weiteren werden Expressionskassetten offenbart, die nach Integration in geeignete Vektoren zur Erzeugung von als Biomonitoren einsetzbaren tragsgenen Hydra genutzt werden können.The invention describes transgenic hydra which, in the presence of at least one stress factor in the surrounding medium, expresses at least one stress factor-inducible reporter gene, the use of this transgenic hydra as biomonitoring system and a method for detecting stress factors in samples by means of transgenic hydra. Furthermore, expression cassettes are disclosed which, after integration into suitable vectors, can be used to generate tragogenic hydra which can be used as biomonitors.
Description
Die Erfindung betrifft als Biomonitoren, insbesondere für die Kontrolle der Trinkwasser- und Gewässerqualität, einsetzbare transgene Hydra, in gängige Vektoren integrierbare Expressionskassetten zu deren Erzeugung sowie ein Verfahren zum Nachweis von Schadstoffen mittels transgenen Hydra.The Invention relates as biomonitors, in particular for the Control of drinking water and water quality, usable transgenic Hydra, integrable in common vectors Expression cassettes for their generation and a method for Detection of pollutants by means of transgenic Hydra.
Die ständig zunehmende Menge an chemischem und mikrobiellem Abfall aus industrieller und anderer menschlicher Aktivität verlangt dringend die Entwicklung von Frühwarnsystemen auf Basis von Biomonitoren. Wissenschaftliche Institutionen erheben seit Jahren die Forderung nach einem biologischen Effektmonitoring, mit welchem sich die Auswirkungen von Umweltgiften und mikrobiellen Keimen auf Organismen nachweisen lassen.The constantly increasing amount of chemical and microbial Waste from industrial and other human activity urges the development of early warning systems based on biomonitors. To raise scientific institutions for years the demand for a biological effect monitoring, with which the effects of environmental toxins and microbial Detect germs on organisms.
Auch in aquatischen Lebensräumen spielen neben der Eutrophierung Umweltgifte und mikrobielle Keime in zunehmendem Maße eine Rolle hinsichtlich der Verbreitung und Diversität von Arten und deren Überlebens- und Fortpflanzungsfähigkeit. Die Mischung der Umweltgifte und mikrobiellen Keime in unseren Gewässern ist dabei unüberschaubar und vielfältig. Gezielte chemische Analytik von einzelnen Substanzen kann immer nur einen kleinen Ausschnitt dieser Mischung erfassen. Entscheidend für die Überlebensfähigkeit der dort lebenden Tiere ist das Zusammenwirken aller vorhandenen Einzelsubstanzen und vieler anderer Faktoren. Es müssen also Methoden zur Detektion gefunden werden, die eine biologische „Antwort" auf das Gemisch an Umweltgiften und mikrobiellen Keimen geben, um mögliche Gefahren frühzeitig zu erkennen. Biochemisch-molekularbiologische Parameter sind für diesen Zweck gut geeignet, weil die Zeit zwischen Ursache (Umweltgift, Mikrobenblüte) und Wirkung (biologischer Effekt) kurz ist, und man somit eine schnelle und auch empfindliche Antwort erhält.Also in aquatic habitats in addition to eutrophication Environmental toxins and microbial germs are becoming increasingly common Role in the distribution and diversity of species and their survival and reproductive capacity. The mixture of environmental toxins and microbial germs in our waters is unmanageable and diverse. targeted Chemical analysis of individual substances can only ever one Gather small section of this mixture. Decisive for the survivability of the animals living there is the interaction of all existing individual substances and many other factors. So there have to be methods for detection be found that have a biological "response" to the Give mixture of environmental toxins and microbial germs to possible To recognize dangers at an early stage. Biochemistry and molecular biology Parameters are well suited for this purpose because the Time between cause (environmental poison, microbial bloom) and effect (biological effect) is short, and thus a fast and also receives sensitive answer.
Im
Rahmen von Gewässer-Überwachungsprogrammen werden
derzeit Schadstoffe in Sedimenten und im Wasser gemessen. Die Bewertungen erfolgen
auf der Grundlage von physikalischen, chemischen und/oder mikrobiologischen
Grenzwerten. Es gibt daneben jedoch auch Methoden, mit denen eine
biologische „Antwort" auf die Anwesenheit von Umweltgiften
und Pathogenen in aquatischen Lebensräumen aufgezeigt werden
kann. Dabei werden mikrobielle, tierische oder pflanzliche Organismen eingesetzt
und als „Bioindikatoren" oder „Biomonitore" bezeichnet,
die auf die Gegenwart von Umweltgiften (z. B. Chemikalien, Schwermetalle)
und/oder anderen Stressfaktoren (z. B. Hitze, Sauerstoffmangel, etc.)
reagieren, im Wesentlichen durch Änderung der Vitalfunktionen
(z. B. Atemfrequenz, Mobilität, Lumineszenz). So wird z.
B. in der
Die
In
der
In
der
Der
Süßwasserpolyp Hydra ist ein seit längerem
etabliertes toxikologisches Testsystem. So werden z. B. die hohen
regenerativen Fähigkeiten dieses basalen Vielzellers bei
der Herstellung „künstlicher Embryos" aus Zellaggregaten
genutzt, die insbesondere für den Nachweis fruchtschädigender
(teratogener) toxikologischer Effekte von Chemikalien eingesetzt
werden können, wie z. B. in der
In
dem
Auf
einem ähnlichen Prinzip beruht das in der
Der
derzeit existierende Stand der Technik weist eine Vielzahl unterschiedlicher
Nachteile auf. Die derzeitigen Grenzen des Einsatzes von Biomonitoren
ergeben sich u. a. aus fehlenden Kenntnissen aus der Grundlagen-
und angewandten Forschung, der mangelnden Aussageschärfe
auf den verschiedenen Ebenen der biologischen Organisation (Zelle, Gewebe,
Organismus), sowie der oft nicht-praktikablen Anwendbarkeit in der
Praxis. So sind z. B. Biomonitoringsysteme, die auf der Analyse
von Atmungsfrequenz und Körperbewegungen von Fischen basieren,
nicht sensitiv genug und daher lediglich in der Lage, akut-toxische
Schadstoffkonzentrationen nachzuweisen. Längerfristig schädliche
Effekte (Fruchtschädigung, Erbgutschädigung, Krebs)
und Schadstoffkonzentrationen, die erst nach mehreren Tagen oder
Wochen zu detektierbaren Symptomen führen, werden von diesen
Biomonitoringsystemen nicht zeitnah erfasst. Der Einsatz im Online-Monitoring,
z. B. bei der Trinkwassergewinnung, ist hiermit nicht praktikabel.
Auch die inzwischen kommerziell erhältlichen, auf dem Einsatz
lumineszierender Organismen beruhenden Monitoringsysteme (z. B.
Microtox-Assay) wirken erst bei vergleichsweise hohen Schadstoffkonzentrationen
oder akut-toxischen Substanzen, die mit einer deutlichen Vitalitäts-
und damit Lumineszenzeinbuße unter den Testorganismen einhergehen.
Transgene mammalische Tiermodelle, wie das bereits angeführte
Mausmodell, bzw. hieraus gewonnene primäre Zellkulturen,
eignen sich organismusbedingt nicht zum kontinuierlichen Online-Monitoring
von z. B. Trinkwasser. Zudem sind eine vergleichsweise aufwendige
Laboranalytik, gegebenenfalls Zellkultureinrichtungen sowie geschultes
Personal erforderlich. Darüber hinaus ist die Herstellung bzw.
Beschaffung der transgenen Mäuse bzw. die Kultivierung
der entsprechenden Zellkulturen sehr kostenintensiv. Transgene Caenorhabditis
elegans, die, wie in der
Aufgabe der vorliegenden Erfindung ist es daher, ein praktikables, sensitives und kostengünstiges Biomonitoringsystem für die Trinkwasser- und Gewässerüberwachung bereitzustellen, das unmittelbar Aufschluss über die Art eines detektierten Stressfaktors gibt.task The present invention is therefore a practical, sensitive and cost effective biomonitoring system for the Provide drinking water and water monitoring, the immediate information about the type of a detected stress factor gives.
Die Aufgabe wird durch die Bereitstellung transgener Hydra mit den in Anspruch 1 aufgeführten Merkmalen gelöst. Die Unteransprüche geben vorteilhafte Ausgestaltungen der Erfindung an.The Task is accomplished by providing transgenic Hydra with the in Claim 1 listed features solved. The Subclaims give advantageous embodiments of the invention at.
Hydra
ist ein in allen aquatischen Lebensräumen verbreiteter
einfacher Organismus. Die Polypen leben in allen Süßgewässern
und reagieren sehr rasch auf eine Verschlechterung der Gewässerqualität
(Schwermetallbelastung etc.) oder der Wassertemperatur mit einer
Stressantwort (
Die Erfinder haben Gene in Hydra entdeckt, die spezifisch von jeweils verschiedenen Umweltsignalen (Stressfaktoren) wie Temperatur, Anwesenheit toxischer Substanzen und mikro biellen Keimen reguliert werden. Hierbei handelt es sich um die Hydra-Gene hsp70.1 (Accession-no. M84019, SEQ ID NO: 1) und Periculin (SEQ ID NO: 2).The Inventors have discovered genes in Hydra that are specific to each different environmental signals (stress factors) such as temperature, presence of toxic Substances and microbial germs are regulated. This acts it is the Hydra genes hsp70.1 (Accession No. M84019, SEQ ID NO: 1) and periculin (SEQ ID NO: 2).
hsp70.1
codiert für das Hydra Heat Shock Protein (HSP) 70. Dieses
Gen wird sehr sensitiv über Temperaturschwankungen in dem
die Hydra umgebenden Wasser reguliert (
Die Transkription des Hydra-Gens Periculin hingegen wird spezifisch durch mikrobielle Wasserverunreinigungen wie Bakterien, Pilze und Viren bzw. durch für diese charakteristische Substanzen, z. B Lipopolysaccharide (LPS) aus gram-negativen Bakterien oder virale doppelsträngige RNA, induziert. Der entsprechende Periculin-Promotor kann daher als sehr sensitiver und spezifischer Regulator für die Transkription eines das Vorliegen einer mikrobiellen Kontamination anzeigenden Reportergens genutzt werden.The Transcription of the hydra gene periculin, on the other hand, becomes specific by microbial water contaminants such as bacteria, fungi and Viruses or by substances characteristic of them, z. B lipopolysaccharides (LPS) from gram-negative bacteria or viral double-stranded RNA, induced. The corresponding Periculin promoter can therefore be considered very sensitive and specific Regulator for the transcription of the presence of a microbial contamination indicating reporter gene can be used.
Die
jeweiligen Promotoren dieser Gene konnten identifiziert und in verschiedene
DNA-Konstrukte (Expressionkassetten) integriert werden. Diese werden
erfindungsgemäß von NotI-Restriktionsschnittstellen
flankiert und können hierüber problemlos in ein
für die Klonierung und Propagation in dem Bakterium Escherichia
coli geeignetes Vektor-Grundgerüst integriert werden. Jede
Expressionskassette enthält einzelne Restriktionsschnittstellen
für die Restriktionsendonukleasen ApaLI, XbaI, BamHI, SbfI, PacI,
AsiSI, AscI und FseI. Diese Schnittstellen ermöglichen
ein leichtes Austauschen und Kombinieren von verschiedenen Promotoren
und Reportergenen. Die Expressionskassetten enthalten jeweils mindestens
einen der vorbezeichneten Stress-Promotoren sowie das jeweilige
von diesem regulierte Reportergen (z. B. GFP, eGFP, YFP, eYFP, CFP,
dsRED, BFP, mTFP1, Emerald, Citrine, mOrange, mApple, mCherry, mGrape).
Dem Reportergen nachgeschaltet ist eine Expressionsterminations-Sequenz,
vorzugsweise der Hydra Actin-Terminator. Ferner kann die Expressionskassette ein
weiteres über Fluoreszenzlicht nachweisbares Reportergen enthalten,
das unter der Kontrolle eines starken konstitutiven Promotors steht.
Dies kann z. B. der Promotor des Hydra Actin-Gens sein, wie in
Durch die Verwendung der so hergestellten transgenen Hydra-Linien als Biomonitoren ist es beispielsweise möglich, automatische Systeme bereitzustellen, in denen die transgenen Hydra kontinuierlich von dem zu überwachenden Wasser umspült werden. Die entsprechenden Hyd ra-Kulturen werden dabei entweder permanent, bevorzugt jedoch, um ein vorzeitiges Ausbleichen der Fluoreszenz zu vermeiden, in regelmäßigen Intervallen kurzfristig mit Fluoreszenzlicht einer geeigneten Anregungswellenlänge bestrahlt. Dies kann z. B. unter Zuhilfenahme eines modifizierten Fluoreszenz-Mikroskops oder vorzugsweise eines Fluoreszenz-Auflichtbinokulars erfolgen. Über eine geeignete Kamera wird die Kultur zu jedem Bestrahlungsintervall auf die Expression der jeweiligen Reportergene hin analysiert. Sollte eins der jeweiligen Reportergenprodukte nachweisbar sein, wird über eine entsprechende Analysesoftware ein Warnsignal generiert und/oder entsprechende Sicherheitsprotokolle aktiviert (z. B. Abschaltung der Wasserversorgung). Natürlich sind die erfindungsgemäßen transgenen Hydra ebenso zur gezielten Untersuchung von aus Süßgewässern entnommenen Wasserproben geeignet. Hierbei werden die Hydra-Kulturen für gewisse Zeit mit den jeweiligen Wasserproben inkubiert und in regelmäßigen Abständen, wie zuvor beschrieben, auf die Expression der jeweiligen Reportergenprodukte überprüft. In Analogie hierzu liegt es auf der Hand, das gegebenenfalls auch in Wasser gelöste, auf Toxizität zu testende Substanzen mit den erfindungsgemäßen transgenen Hydra auf deren biologischen Effekt überprüft werden können.By the use of the transgenic hydra-lines thus prepared as Biomonitoren it is possible, for example, automatic To provide systems in which the transgenic hydra is continuous be lapped by the monitored water. The corresponding hydra cultures are either permanent, preferred, however, to premature bleaching of the fluorescence avoid at regular intervals in the short term irradiated with fluorescent light of a suitable excitation wavelength. This can be z. B. with the aid of a modified fluorescence microscope or preferably a fluorescence Auflichtbinokulars done. about A suitable camera is the culture at each irradiation interval analyzed for the expression of the respective reporter genes. Should One of the respective reporter gene products will be detectable a corresponding analysis software generates a warning signal and / or corresponding security protocols activated (eg shutdown the water supply). Of course, the invention transgenic hydra also for the targeted study of freshwater taken water samples suitable. Here are the hydra cultures incubated with the respective water samples for a certain time and at regular intervals, as before described on the expression of the respective reporter gene products. By analogy, it is obvious, if necessary, too dissolved in water, toxicity substances to be tested with the transgenic hydra according to the invention their biological effect can be checked.
Der Einsatz von transgenen Hydra, die beim Vorliegen eines bestimmten Stressfaktors in dem sie umgebenden Medium ein bestimmtes Reportergen exprimieren, erlaubt somit die praktikable, sensitive und kostengünstige Überwachung der Qualität von Trinkwasser und Gewässern. Ferner ermöglicht der Einsatz transgener Hydra auch Aussagen zu funktionellen und strukturellen Änderungen auf der Ebene von Zellen und Geweben. Dazu gehören u. a. die Erfassung von oxidativem Stress, pathologische Gewebeveränderungen, Enzymhemmungen, Dysfunktionen der Zelldifferenzierung, gentoxische Effekte und vieles mehr.The use of transgenic hydra, which in the presence of a specific stress factor in the surrounding medium a specific reporter gene express, thus allowing the practicable, sensitive and cost-effective monitoring of the quality of drinking water and water. Furthermore, the use of transgenic Hydra also allows statements on functional and structural changes at the level of cells and tissues. These include the detection of oxidative stress, pathological tissue changes, enzyme inhibition, dysfunctions of cell differentiation, genotoxic effects and much more.
Die
Erfindung wird in den
In
Eine
detailiertere Darstellung der in den in
In
In
Die
transgenen Hydra wurden, wie in
zur Transfektion der Hydra-Polypen
werden Reportergenkonstrukte eingesetzt. Die Transfektion erfolgt mittels
Mikroinjektion von H. vulgaris (AEP) Embryos im 2–8 Zell
Stadium.The transgenic Hydra were, as in
Reporter gene constructs are used to transfect the hydra polyps. Transfection is by microinjection of H. vulgaris (AEP) embryos in the 2-8 cell stage.
Vor der Mikroinjektion werden die Embryos vom mütterlichen Gewebe abgelöst. Die Mikroinjektion wird unter einem invertierten Mikroskop (Zeiss Axiovert 100) und zwei Mikromanipulatoren (Leitz, Eppendorf) durchgeführt. Embryos werden unter Zuhilfenahme einer CellTram Air Pumpe (Eppendorf) mit einer Mikropipette gehalten. Das jeweilige Konstrukt (0.1 μl; 0.6 μg Vektor/μl) wird mit einer CellTram vario Pumpe (Eppendorf) injiziert. Die Glassnadeln für die Mikroinjektion werden mit einem Vertical Pipette Puller 700 C (Kopf Instruments, Tujunga, CA) hergestellt. Zwischen 20 und 30% der Embryonen exprimieren das Konstrukt von Tag 2 an. Nach dem Schlüpfen exprimieren die Polypen das Reportergen als „Mosaike" in kleinen Zellgruppen. Durch klonale Propagation werden aus solchen Gründerpolypen Polypen hergestellt, die das Expressionskonstrukt in allen Zellen des Körpers oder der betreffenden Zelllinie tragen.Before the microinjection, the embryos are detached from the maternal tissue. The microinjection is performed under an inverted microscope (Zeiss Axiovert 100) and two micromanipulators (Leitz, Eppendorf). Embryos become under aid of a CellTram Air pump (Eppendorf) with a micropipette. The respective construct (0.1 μl, 0.6 μg vector / μl) is injected with a CellTram vario pump (Eppendorf). The glass needles for microinjection are made with a Vertical Pipette Puller 700 C (Kopf Instruments, Tujunga, CA). Between 20 and 30% of the embryos express the construct from day 2 onwards. After hatching, the polyps express the reporter gene as "mosaics" in small groups of cells, and clonal propagation produces polyps from such founder polyps that carry the expression construct in all cells of the body or cell line.
Es folgt ein Sequenzprotokoll nach WIPO St. 25.It follows Sequence listing according to WIPO St. 25. Dieses kann von der amtlichen Veröffentlichungsplattform des DPMA heruntergeladen werden.This can of the official publication platform of the DPMA.
ZITATE ENTHALTEN IN DER BESCHREIBUNGQUOTES INCLUDE IN THE DESCRIPTION
Diese Liste der vom Anmelder aufgeführten Dokumente wurde automatisiert erzeugt und ist ausschließlich zur besseren Information des Lesers aufgenommen. Die Liste ist nicht Bestandteil der deutschen Patent- bzw. Gebrauchsmusteranmeldung. Das DPMA übernimmt keinerlei Haftung für etwaige Fehler oder Auslassungen.This list The documents listed by the applicant have been automated generated and is solely for better information recorded by the reader. The list is not part of the German Patent or utility model application. The DPMA takes over no liability for any errors or omissions.
Zitierte PatentliteraturCited patent literature
- - DD 238113 A1 [0004] - DD 238113 A1 [0004]
- - DE 69825873 T2 [0005] - DE 69825873 T2 [0005]
- - DE 4440320 [0006] - DE 4440320 [0006]
- - US 6340572 B1 [0007] - US 6340572 B1 [0007]
- - US 4346070 [0008] US 4346070 [0008]
- - US 5877398 [0009, 0011] US 5877398 [0009, 0011]
- - WO 99/11772 [0010] WO 99/11772 [0010]
Zitierte Nicht-PatentliteraturCited non-patent literature
- - Arkhipchuk et al. („Use of Hydra for chronic toxicity assessment of waters intended for human consumption” Environ Pollut. 2006 Jul; 142(2): 200–11) [0008] Arkhipchuk et al. Environ Pollut, 2006 Jul; 142 (2): 200-11) [0008] ("Use of Hydra for chronic toxicity assessment of water intended for human consumption" Environ Pollut.
- - Pardos et al. („Acute toxicity assessment of Polish (waste) water with a microplate-based Hydra attenuata assay: a comparison with the Microtox test.” Sci Total Environ. 1999 Dec 15; 243–244: 141–8) [0008] - Pardos et al. ("Acute toxicity assessment of polish (waste) water with a microplate-based hydra attenuata assay: a comparison with the Microtox test." Sci Total Environ. 1999 Dec 15; 243-244: 141-8) [0008]
- - Fu et al. („Application of the Hydra attenuata assay for identifying developmental hazards among natural waters and wastewaters." Ecotoxicol Environ Saf. 1991 Dec; 22(3): 309–19) [0008] - Fu et al. ("Application of the Hydra attenuata assay for identifying developmental hazards among natural waters and wastewater." Ecotoxicol Environ Saf. 1991 Dec; 22 (3): 309-19) [0008]
- - Pardos et al. „Acute toxicity assessment of Polish (waste) water with a microplate-based Hydra attenuata assay: a comparison with the Microtox test." Sci Total Environ. 1999 Dec 15; 243–244: 141–8 [0011] - Pardos et al. "Acute toxicity assessment of Polish (waste) water with a microplate-based hydra attenuata assay: a comparison with the Microtox test." Sci Total Environ. 1999 Dec 15; 243-244: 141-8 [0011]
- - Bosch et al. „Thermotolerance and synthesis of hegt shock Proteins: these responses are present in Hydra attenuata but absent in Hydra oligactis." Proc Natl Acad Sci USA, 1988 Nov; 85(21): 7927–31 [0014] - Bosch et al. "Thermotolerance and synthesis of shock proteins: these responses are present in hydra attenuate but absent in Hydra oligactis." Proc Natl Acad Sci USA, 1988 Nov; 85 (21): 7927-31 [0014]
- - Gellner et al. „Cloning and expression of an hegt inducible hsp 70 gene in two species of hdra which differ in their stress response" Eur J Biochem 1992, 210, 683–691 [0016] Gellner et al. "Cloning and expression of an inducible hsp 70 genes in two species of hdr which differ in their stress response" Eur J Biochem 1992, 210, 683-691 [0016]
- - Wittlieb et al. („Transgenic Hydra allow in vivo tracking of individual stem cells during morphogenesis.” Proc Natl Acad Sci U S A. 2006 Apr 18; 103(16): 6208–11 [0018] - Wittlieb et al. ("Transgenic Hydra Allow In Vivo Tracking of Individual Stem Cells During Morphogenesis." Proc Natl Acad Sci USA 2006 Apr 18; 103 (16): 6208-11 [0018]
- - Wittlieb et al. („Transgenic Hydra allow in vivo tracking of individual stem cells during morphogenesis.” Proc Natl Acad Sci U S A. 2006 Apr 18; 103(16): 6208–11 [0034] - Wittlieb et al. ("Transgenic Hydra allow in vivo tracking of individual stem cells during morphogenesis." Proc Natl Acad Sci USA 2006 Apr 18; 103 (16): 6208-11 [0034]
Claims (19)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102007035238A DE102007035238A1 (en) | 2007-07-27 | 2007-07-27 | Biological effect monitoring by transgenic Hydra |
| PCT/DE2008/001086 WO2009015623A1 (en) | 2007-07-27 | 2008-06-25 | Biological effect monitoring by means of transgenic hydra |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102007035238A DE102007035238A1 (en) | 2007-07-27 | 2007-07-27 | Biological effect monitoring by transgenic Hydra |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE102007035238A1 true DE102007035238A1 (en) | 2009-01-29 |
Family
ID=39832526
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE102007035238A Withdrawn DE102007035238A1 (en) | 2007-07-27 | 2007-07-27 | Biological effect monitoring by transgenic Hydra |
Country Status (2)
| Country | Link |
|---|---|
| DE (1) | DE102007035238A1 (en) |
| WO (1) | WO2009015623A1 (en) |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4346070A (en) | 1980-04-11 | 1982-08-24 | Thomas Jefferson University | Test for teratogenic potential employing hydra |
| DD238113A1 (en) | 1985-06-06 | 1986-08-06 | Binnenfischerei Dresden Veb | METHOD AND DEVICE FOR MONITORING WATER ON HAZARDOUS SUBSTANCES |
| DE4440320A1 (en) | 1994-11-11 | 1995-03-30 | Wilfried Dr Rer Nat Pauli | Method and apparatus for detecting environmental pollution by chemicals in aqueous samples using bioindicators |
| US5877398A (en) | 1993-01-29 | 1999-03-02 | University Of British Columbia | Biological systems incorporating stress-inducible genes and reporter constructs for environmental biomonitoring and toxicology |
| WO1999011772A1 (en) | 1997-08-28 | 1999-03-11 | Consiglio Nazionale Delle Ricerche | Transgenic animals for the study of biological, physical and chemical toxic agents |
| US6340572B1 (en) | 1991-04-04 | 2002-01-22 | Board Of Regents, The University Of Texas System | Kit for the isolation, identification and quantitation of toxicants |
| DE69825873T2 (en) | 1997-03-17 | 2005-09-01 | United States as represented by the Secretary of the Army U.S. Army Center for Environmental Health Research | METHOD FOR AUTOMATIC BIOLOGICAL MONITORING OF WATER QUALITY |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0948612A2 (en) * | 1997-01-03 | 1999-10-13 | University Technology Corporation | Beta-amyloid toxicity |
| EP1519755B1 (en) * | 2002-03-26 | 2008-05-07 | Nanocyte Inc. | Stinging cells expressing an exogenous polynucleotide encoding a therapeutic, diagnostic or a cosmetic agent and methods compositions and devices utilizing such stinging cells or capsules derived therefrom for delivering the therapeutic, diagnostic or cosmetic agent into a tissue |
-
2007
- 2007-07-27 DE DE102007035238A patent/DE102007035238A1/en not_active Withdrawn
-
2008
- 2008-06-25 WO PCT/DE2008/001086 patent/WO2009015623A1/en not_active Ceased
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4346070A (en) | 1980-04-11 | 1982-08-24 | Thomas Jefferson University | Test for teratogenic potential employing hydra |
| DD238113A1 (en) | 1985-06-06 | 1986-08-06 | Binnenfischerei Dresden Veb | METHOD AND DEVICE FOR MONITORING WATER ON HAZARDOUS SUBSTANCES |
| US6340572B1 (en) | 1991-04-04 | 2002-01-22 | Board Of Regents, The University Of Texas System | Kit for the isolation, identification and quantitation of toxicants |
| US5877398A (en) | 1993-01-29 | 1999-03-02 | University Of British Columbia | Biological systems incorporating stress-inducible genes and reporter constructs for environmental biomonitoring and toxicology |
| DE4440320A1 (en) | 1994-11-11 | 1995-03-30 | Wilfried Dr Rer Nat Pauli | Method and apparatus for detecting environmental pollution by chemicals in aqueous samples using bioindicators |
| DE69825873T2 (en) | 1997-03-17 | 2005-09-01 | United States as represented by the Secretary of the Army U.S. Army Center for Environmental Health Research | METHOD FOR AUTOMATIC BIOLOGICAL MONITORING OF WATER QUALITY |
| WO1999011772A1 (en) | 1997-08-28 | 1999-03-11 | Consiglio Nazionale Delle Ricerche | Transgenic animals for the study of biological, physical and chemical toxic agents |
Non-Patent Citations (11)
| Title |
|---|
| Arkhipchuk et al. ("Use of Hydra for chronic toxicity assessment of waters intended for human consumption" Environ Pollut. 2006 Jul; 142(2): 200-11) |
| bi Hydra und Drosphila: HASSEL, M. 20.04.2007. Ku rzbeschreibung |
| bi Hydra und Drosphila: HASSEL, M. 20.04.2007. Kurzbeschreibung; * |
| Bosch et al. "Thermotolerance and synthesis of hegt shock Proteins: these responses are present in Hydra attenuata but absent in Hydra oligactis." Proc Natl Acad Sci USA, 1988 Nov; 85(21): 7927-31 |
| Fu et al. ("Application of the Hydra attenuata assay for identifying developmental hazards among natural waters and wastewaters." Ecotoxicol Environ Saf. 1991 Dec; 22(3): 309-19) |
| Gellner et al. "Cloning and expression of an hegt inducible hsp 70 gene in two species of hdra which differ in their stress response" Eur J Biochem 1992, 210, 683-691 |
| GELLNER, K., PRAETZEL, G., BOSCH, T.C.G.: Coning a nd expression of a heatinducible hsp70 gene in two species of Hydra which differ in their stress res ponse. 1992. In: Eur. J. Biochem., Vol. 210, S 683 -691; Internet-Recherche am 15.10.2008: www.tzm-ma rburg.de/forschung- info/forschungsbericht/einzel9 9.cfm? FB=17&Institut=131&lfd&_Nr=16p Vergleichend e funktionelle Analyse der evolutionären Konservie rung von Fibroblasten-Wachstumsfaktor- Rezeptoren |
| GELLNER, K., PRAETZEL, G., BOSCH, T.C.G.: Coning and expression of a heatinducible hsp70 gene in two species of Hydra which differ in their stress response. 1992. In: Eur. J. Biochem., Vol. 210, S 683-691; * |
| Internet-Recherche am 15.10.2008: www.tzm-marburg.de/forschung-info/forschungsbericht/einzel99.cfm? FB=17&Institut=131&lfd&_Nr=16p Vergleichende funktionelle Analyse der evolutionären Konservierung von Fibroblasten-Wachstumsfaktor-Rezeptoren; * |
| Pardos et al. ("Acute toxicity assessment of Polish (waste) water with a microplate-based Hydra attenuata assay: a comparison with the Microtox test." Sci Total Environ. 1999 Dec 15; 243-244: 141-8) |
| Wittlieb et al. ("Transgenic Hydra allow in vivo tracking of individual stem cells during morphogenesis." Proc Natl Acad Sci U S A. 2006 Apr 18; 103(16): 6208-11 |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2009015623A1 (en) | 2009-02-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Valenzano et al. | Transposon-mediated transgenesis in the short-lived African killifish Nothobranchius furzeri, a vertebrate model for aging | |
| DE69635992T2 (en) | AN AUTOREGULATED TETRACYCLIN-REGULATED SYSTEM FOR INDUCED GENE EXPRESSION IN EUKARYOTES | |
| DE69807687T2 (en) | TRANSGENIC FISH WITH TISSUE-SPECIFIC EXPRESSION | |
| Bodhicharla et al. | Effects of α-synuclein overexpression in transgenic Caenorhabditis elegans strains | |
| WO2015088039A1 (en) | Cancer detection method using sense of smell of nematode | |
| Asakawa et al. | Cellular dissection of the spinal cord motor column by BAC transgenesis and gene trapping in zebrafish | |
| Malicki et al. | Analysis of gene function in the zebrafish retina | |
| Kukhtar et al. | Synthetic biology in multicellular organisms: Opportunities in nematodes | |
| Wayne et al. | Whole-cell electrophysiology of gonadotropin-releasing hormone neurons that express green fluorescent protein in the terminal nerve of transgenic medaka (Oryzias latipes) | |
| JP2004500866A (en) | C. Assay technique based on anagen-dependent expression of elegans | |
| Link et al. | Zebrafish as a Model for Development | |
| DE102007035238A1 (en) | Biological effect monitoring by transgenic Hydra | |
| DE69926629T2 (en) | TRANSGENIC FISH CARRYING A TRANSGENIC CONSTRUCT FOR THE DETECTION OF MUTATIONS DERIVED FROM BACTERIOPHAGES | |
| Silic et al. | Visualization of cellular electrical activity in zebrafish early embryos and tumors | |
| US8487087B2 (en) | Model animal in which state of disease condition is observable in real time, gene construct for achieving the same and use of the same | |
| US20060115895A1 (en) | Fish disease models and uses thereof | |
| US20040031065A1 (en) | Neuronal activation in a transgenic model | |
| KR20090097504A (en) | Evaluation of Toxic Developmental Toxicity through Fluorescent Protein Expression in Transgenic Embryos in Animals | |
| DE60225839T2 (en) | MEANS FOR ISOLATING LIVABLE CELLS EXPRESSING C-KIT | |
| EP3835421A1 (en) | Vectors for tissue specific transcriptomics | |
| Giraldo et al. | A neurogenetic toolkit to decode Anopheles gambiae olfaction | |
| de Almeida | Optimization of in Vivo Electroporation and Comparison to Microinjection as Delivery Methods for Transgenesis in Zebrafish (Danio Rerio) Generation of a New Neuronal Zebrafish Line | |
| Agostinho Pina da Silva | Unveiling the Ancestral Function of a Neuroendocrine Regulator, POU-I/Pit1: Insights from Gene Expression Analysis in the Sea Anemone Nematostella vectensis | |
| da Silva | Unveiling the Ancestral Function of a Neuroendocrine Regulator, POU-I/Pit1: Insights from Gene Expression Analysis in the Sea Anemone Nematostella vectensis | |
| Hamza et al. | 4 Cellular and Genetic |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| OP8 | Request for examination as to paragraph 44 patent law | ||
| 8139 | Disposal/non-payment of the annual fee |